Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasms, Pancreas”

5,089 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 5,089 results

Testing effectiveness (Phase 2)Study completedNCT05586516
What this trial is testing

Assess an ATX Inhibitor (IOA-289) in Patients With Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
iOnctura 16
Not applicableUnknownNCT02479984
What this trial is testing

Diagnostic Laparoscopy in the Preoperative Staging of Pancreatobiliary Cancer

Who this might be right for
Pancreatic Cancer
National Cancer Center, Korea 193
Large-scale testing (Phase 3)Study completedNCT01121848
What this trial is testing

Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
Sanofi 108
Testing effectiveness (Phase 2)UnknownNCT00178763
What this trial is testing

Hyperthermia With Chemotherapy for Locally Advanced or Metastatic Pancreas Cancer

Who this might be right for
Pancreatic Neoplasms
The University of Texas Health Science Center, Houston 36
Testing effectiveness (Phase 2)Ended earlyNCT00889187
What this trial is testing

Neoadjuvant Accelerated Short Course Radiation Therapy With Photons and Capecitabine for Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Dana-Farber Cancer Institute 10
Testing effectiveness (Phase 2)Looking for participantsNCT06662006
What this trial is testing

Nal-IRI/5-FU/LV Chemotherapy Combined With PD-L1 Inhibitor and Multi-target Anti-angiogenic Small Molecule±SBRT as Second-line Therapy in Metastatic Pancreatic Cancer Patients

Who this might be right for
Advanced Metastatic Pancreatic Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 56
Testing effectiveness (Phase 2)Temporarily pausedNCT03417921
What this trial is testing

ABTL0812 in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Ability Pharmaceuticals SL 60
Not applicableEnded earlyNCT00923052
What this trial is testing

The Natural History of Solid Organ Cancer Stem Cells (SOCSC)

Who this might be right for
Hepatic CancerPancreatic Ductal CancerColorectal Cancer+2 more
National Cancer Institute (NCI) 190
Early research (Phase 1)Study completedNCT05383352
What this trial is testing

Compare Onivyde Manufactured at Two Different Production Sites in Adult Participants With Advanced Cancer in the Pancreas

Who this might be right for
Metastatic Pancreatic Adenocarcinoma
Ipsen 177
Testing effectiveness (Phase 2)Study completedNCT00002955
What this trial is testing

Combination Chemotherapy in Treating Patients With Advanced Cancer of the Pancreas

Who this might be right for
Pancreatic Cancer
University of Southern California 21
Post-approval studies (Phase 4)Ended earlyNCT06077487
What this trial is testing

Ketamine-assisted Therapy for Advanced GI Cancer

Who this might be right for
Pancreatic Ductal AdenocarcinomaPain, AcuteGastrointestinal Cancers+1 more
Brian Anderson, MD 1
Testing effectiveness (Phase 2)Temporarily pausedNCT06211933
What this trial is testing

Evaluation of the High Intensity Focused Ultrasound (HIFU) Technique for Patients With Unresectable Pancreatic Tumor Treatment (PULS)

Who this might be right for
Non-Resectable Pancreas Carcinoma
Centre Leon Berard 26
Early research (Phase 1)Not Yet RecruitingNCT06203821
What this trial is testing

Study of Perioperative NP137 and FOLFIRINOX in Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Aram Hezel 25
Not applicableStudy completedNCT04330716
What this trial is testing

Genetic Testing for Breast, Ovarian, Pancreatic, and Prostate Cancers

Who this might be right for
Breast CancerOvarian CancerPancreatic Cancer+1 more
Dana-Farber Cancer Institute 269
Testing effectiveness (Phase 2)Active Not RecruitingNCT06710132
What this trial is testing

Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)

Who this might be right for
Solid TumorsGastric CancerNon-Small Cell Lung Cancer (NSCLC)+2 more
EMD Serono Research & Development Institute, Inc. 184
Early research (Phase 1)Study completedNCT02646748
What this trial is testing

Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors

Who this might be right for
Colorectal Cancer (CRC)Endometrial CancerMelanoma+8 more
Incyte Corporation 159
Early research (Phase 1)Study completedNCT01051284
What this trial is testing

Gemcitabine and Cyberknife Radiation Therapy for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Georgetown University 14
Not applicableUnknownNCT03621852
What this trial is testing

Prospective Evaluation of the Diagnostic Efficacy of a EUS Guided FNB Needle (AQUIRE®)

Who this might be right for
Tumors of the PancreasSubmucosal Tumor of Gastrointestinal Tract (Disorder)Lymph Node Disease
Philipps University Marburg 40
Not applicableAvailableNCT06872489
What this trial is testing

Expanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid Tumors

Who this might be right for
Neuroblastoma in ChildrenNeuroblastoma, Recurrent, RefractoryAdvanced Cancer+7 more
Second Life Therapeutics
Testing effectiveness (Phase 2)WithdrawnNCT06090318
What this trial is testing

Milademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A Loss

Who this might be right for
Advanced Solid TumorCDKN2ANSCLC+7 more
Rain Oncology Inc
Next Page